Skip to main content
Clinical Trials/NCT04753983
NCT04753983
Withdrawn
Not Applicable

fMRI of Active DBS Stimulation in Epilepsy

Mayo Clinic0 sitesSeptember 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Refractory Epilepsy
Sponsor
Mayo Clinic
Primary Endpoint
Document brain activation networks with ANT stimulation
Status
Withdrawn
Last Updated
3 years ago

Overview

Brief Summary

The purpose of this study is to use functional imaging to study the mechanisms of the anterior nucleus of the thalamus (ANT) deep brain stimulation (DBS).

Detailed Description

Researchers are testing how changing the settings on deep brain stimulation device (DBS) can help reduce the number and severity of seizures. Functional imaging will be used to study the mechanisms of ANT DBS to optimize the device settings to improve the degree of seizure reduction.

Registry
clinicaltrials.gov
Start Date
September 2022
End Date
May 2024
Last Updated
3 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Steven A. Messina

Principal Investigator

Mayo Clinic

Eligibility Criteria

Inclusion Criteria

  • Patients who have previously undergone anterior thalamic nucleus deep brain stimulation (DBS) for refractory epilepsy.

Exclusion Criteria

  • Contraindication to MRI; prior brain resective surgery or large area of brain tissue loss (e.g., large area infarction).

Outcomes

Primary Outcomes

Document brain activation networks with ANT stimulation

Time Frame: Results would be available immediately following processing of the imaging data after each scan

Use resting state fMRI to map brain network activation with high and low frequency of ANT stimulation.

Similar Trials